title: "We will know it when we see it;" bevacizumab and glioblastoma.
authors.affiliation: University of California San Francisco, Department of Neurological Surgery, Neuro-Oncology Service, 400 Parnassus, Room A-808, San Francisco, CA 94143-0372.
authors.forename: Michael D
authors.initials: MD
authors.lastname: Prados
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000068258:Bevacizumab; D002986:Clinical Trials as Topic; D005909:Glioblastoma / Q000188:drug therapy*; D006801:Humans; D011379:Prognosis
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068258:Bevacizumab